Ambrx Biopharma Cayman, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
La Jolla, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Ambrx Biopharma Cayman, Inc. has filed 164 SEC EDGAR filings since 03 Feb 2021

SEC filing history

Showing 26-50 of 164 matching filings.

Per page
25
Current page
2
4

4 filing

Filing date
28 Jun 2023
Reporting date
27 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-92634

AMBRX BIOPHARMA INC.

Filing date
28 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2023
Reporting date
18 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2023
Reporting date
07 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2023
Reporting date
07 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2023
Reporting date
07 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2023
Reporting date
07 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 May 2023
Reporting date
18 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-92634

AMBRX BIOPHARMA INC.

Filing date
25 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-271008

424B5

Filing date
25 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
19 May 2023
Reporting date
18 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-40505

DEFA14A

Filing date
18 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-271966

S-8

Filing date
16 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 May 2023
Reporting date
28 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
05 May 2023
Reporting date
28 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-271008

EFFECT filing

Filing date
02 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Apr 2023
Reporting date
26 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Apr 2023
Reporting date
26 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .